Home
Centre for Cancer Biomarkers CCBIO

CCBIO Seminars

CCBIO has a monthly research seminar where invited guests and international speakers or the principal and associate investigators focus on current research topics and updates. The CCBIO seminar has been well visited and received.

Collage of photos from the CCBIO seminars.
Photo:
Eli Vidhammer/Jørgen Barth/Oleg Tsinkalovsky

Seminars in 2020

    09.01.20, Cancer in the News

    CCBIO Special Seminar on the topic Cancer in the News. Speakers: Irmelin W Nilsen, UiB, Mille S Stenmarck, UiB, Tine Dommerud, Aftenposten and Knut Helland, UiB.
    Time: 13:00
    Place: Auditorium 4, BBB
    Chairperson: Roger Strand

    30.01.20, Johannes A. Eble

    Johannes Eble, Institute of Physiological Chemistry and Pathobiochemistry, Cells in Motion Interfaculty Centre, University of Münster, Germany.
    Title: "Beating around the bush, yet hitting the point: CAFs and vasculogenic mimicry vessels as anticancer targets"
    Time: 14:30
    Place: Auditorium 4, BBB
    Chairperson: Donald Gullberg

    31.01.20, Iain Johnston

    CCBIO Special Seminar with speaker Iain Johnston, Department of Mathematics, University of Bergen.
    Title: "HyperTraPS: Learning pathways of disease (and cancer) progression from data."
    Time: 15:15
    Place: Auditorium H113, Hospital main building
    Chairperson: Line Bjørge

    20.02.20, Rameen Beroukhim

    Rameen Beroukhim, Associate Professor of Medical Oncology at the Dana-Farber Cancer Institute and Harvard Medical School, and Associate Member of the Broad Institute.
    Title: "Ancestry-associated features in cancer
    Time: 14:30
    Place: Auditorium 4, BBB
    Chairperson: Camilla Krakstad

    19.03.20, Akinyemi Ojesina - CANCELLED - 

    Akinyemi Ojesina, Assistant Professor in the Department of Epidemiology at the University of Alabama at Birmingham (UAB), and an Adjunct Faculty Investigator at the HudsonAlpha Institute for Biotechnology.
    Title: "Interplay of Microbial Influences and Genomic Alterations in Cancer"
    Time: 14:30
    Place: Auditorium 4, BBB
    Chairperson: Camilla Krakstad

    30.04.20,  CANCELLED  

    Title: TBA
    Time: 14:30
    Place: Auditorium 4, BBB
    Chairperson

    28.05.20, JianFeng Chen

    Professor JianFeng Chen, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China.
    Title: Regulation of immune cell trafficking by extracellular microenvironment
    Time: 10:00
    Place: Digital event, as a webinar in Zoom
    Chairperson: Donald Gullberg.

    11.06.20, Biaoyang Lin

    Biaoyang Lin, Zhejiang University, China.
    Title: "Critical roles of Chitinase 3-like 1 (CHI3L1) in inflammation, fibrosis and cancer"
    Time: 14:30
    Place: Digital event, as a webinar in Zoom
    Chairperson: Karl-Henning Kalland.

    27.08.20, Ritva Heljasvaara

    Ritva Heljasvaara, University of Oulu, Finland
    Title: "Novel roles of collagens and a11 integrin in solid cancers"
    Time: 14:30
    Place: Digital event, as a webinar in Zoom
    Chairperson: Donald Gullberg

    24.09.20, Joyce Bischoff

    Joyce Bischoff, Professor of Surgery at Harvard Medical School with a primary appointment in the Vascular Biology Program and Department of Surgery at Boston Children’s Hospital.
    Title: "Endothelial Anomalies in Vascular Tumors and Vascular Malformations"
    Time: 14:00
    Place: Digital event, as a webinar in Zoom
    Chairperson: Elisabeth Wik

    28.09.20, Hong Chen

    CCBIO Special Seminar with speaker Hong Chen, Principal Investigator and Research Associate at Vascular Biology Program in Boston Children’s Hospital and Associate Professor at Harvard Medical School.
    Title: “Endocytic Adaptor Protein Epsin is a Gatekeeper of the Quiescent Endothelium
    Time: 14:00
    Place: Digital event, as a webinar in Zoom
    Chairperson: Elisabeth Wik

    30.09.20. Edward R. Smith

    CCBIO Special Seminar with speaker Edward R. Smith, professor of neurosurgery at Harvard Medical School, the R. Michael Scott Chair in Neurosurgery at Boston Children’s Hospital and the Co-Director of the Cerebrovascular Surgery and Interventions Center.
    Title: “Learning from tumor to treat stroke
    Time: 14:00
    Place: Digital event, as a webinar in Zoom
    Chairperson: Elisabeth Wik

    01.10.20, Mike Rogers

    CCBIO Special Seminar with Mike Rogers, Assistant Professor of Surgery, Harvard Medical School and Research Associate, Vascular Biology Program, Boston Children's Hospital.
    Title: “Metastasis without a tumor
    Time: 14:00
    Place: Digital event, as a webinar in Zoom
    Chairperson: Elisabeth Wik

    21.10.20, Mini Symposium on Endometrial Cancer

    Title: "Endometrial cancer - How will new molecular knowledge influence the way we are treating our patients?"
    Speakers: Alicia Leon del Castillo, Leiden, Alexandra Leary, Paris, Mansoor R Mirza, Copenhagen, Katrine Woie, Bergen, and Ane Gerda Zahl Eriksson, Oslo.
    Time: 15:00 - 17.00
    Place: Digital event, as a webinar in Zoom
    Chairpersons: Camilla Krakstad and Line Bjørge

    05.11.20, Huocong Huang

    Speaker: Huocong Huang, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Title: Heterogeneity of cancer-associated fibroblasts in pancreatic cancer
    Time: 14:30
    Place: Digital event, as a webinar in Zoom
    Chairperson: Jim Lorens

    26.11.20, Fréderic Amant

    Speaker: Professor Frédéric Amant, KU Leuven, Belgium and University of Amsterdam, the Netherlands.
    Title: “Exploiting patient-derived preclinical models to identify biomarkers of response/resistance to therapy in (high grade) gynecological cancers
    Time: 14:30
    Place: Digital event, as a webinar in Zoom
    Chairperson: Camilla Krakstad

    17.12.20, Jean Paul Thiery

    Speaker: Jean Paul Thiery, Bioland Laboratory, Guangzhou Regenerative Medicine and Health, People’s Republic of China, and CCBIO, University of Bergen, Norway
    Title: "Epithelial mesenchymal transition in carcinoma; therapeutic intervention"
    Time: 14:30
    Place: Digital event, as a webinar in Zoom
    Chairperson: Agnete Engelsen

     

    Seminars in 2019

    31.01.19, Cord Brakebusch

    Cord Brakebusch, Biotech Research and Innovation Center (BRIC), University of Copenhagen, Denmark
    Title:  "Epigenetic control of skin inflammation"
    Time: 14:30
    Place: Auditorium 4, BBB
    Chairperson: Donald Gullberg

    06.02.19, Opening Symposium for the Hyperion Imaging System

    CCBIO Special Seminar
    Introduction to the research possibilities offered by the Hyperion Imaging System and examples of groundbreaking research in a high level keynote lecture by Dr. Dario Bressan, Head of the IMAXT Laboratory, CRUK Cambridge Institute, University of Cambridge, UK.
    Link to info and abstracts.
    Time: 13:00
    Place: Auditorium 2, BBB

    21.02.19, Diane Bielenberg

    Diane Bielenberg, Assistant Professor, Vascular Biology Program, Boston Children’s Hospital, Department of Surgery, Harvard Medical School
    Title: "Targeting Neuropilin Pathways to Inhibit Metastasis"
    Time: 14:30
    Place: Auditorium 4, BBB
    Chairperson: Elisabeth Wik

    28.03.19, Gaoxiang Ge  

    Gaoxiang Ge, Shanghai institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China
    Title: "Extracellular Matrix Remodeling in Tissue Homeostasis and Diseases"
    Time: 14:30
    Place: Auditorium 4, BBB
    Chairperson: Donald Gullberg

    25.04.19, Øystein Rekdal

    Øystein Rekdal, PhD, from Lytix Biopharma AS and The Arctic University of Norway, Tromsø
    Title: "From Bench to Bedside with a first in class oncolytic peptide"
    Time: 14:30
    Place: Auditorium 4, BBB
    Chairperson: Bjørn Tore Gjertsen

    23.05.19, Valerie Weaver

    Valerie M. Weaver, Center for Bioengineering and Tissue Regeneration, Department of Surgery, University of California San Francisco (UCSF), San Francisco, CA, USA
    Title: "Forcing tumor risk, transformation and aggression"
    Place: Auditorium 4, BBB
    ChairpersonLars A. Akslen

    06.06.19, Joanna Phillips

    Joanna Phillips, UCSF Department of Neurological Surgery, Helen Diller Cancer Center, University of California San Francisco, CA, USA
    Title: "GBM heterogeneity and extracellular regulation of oncogenic signaling"
    Time: 14:30
    Place: Auditorium 4, BBB
    ChairpersonMarion Kusche-Gullberg

    15.08.19, Innovation in Cancer Therapy

    CCBIO Special Seminar. Speakers from Alden Cancer Therapy II, BerGenBio, DC Prime, KINN Therapeutics, Pfizer Norway, PubGene, SINTEF
    Time: 12:30
    Place: Auditorium 4, BB-building
    Chairperson: Bjørn Tore Gjertsen

    05.09.19, Sushma-Nagaraja Grellscheid

    Sushma-Nagaraja Grellscheid, Associate Professor at the Department of Biological Sciences (BIO), University of Bergen, on the topic of RNA splicing.
    Title: Understanding alternative splicing regulation in health and disease.
    Time: Thursday September 5th at 14:30
    Place: Auditorium 4, BB-building
    Chairperson: Agnete Engelsen

    18.09.19, Bruce Baguley

    CCBIO Special Seminar with invited speaker Professor Bruce Baguley, University of Auckland, Auckland Cancer Society Research Centre, New Zealand
    Title: Do human cancer cell lines really behave in the same way as clinical tumor material?
    Time: 14:30
    Place: Auditorium 4, BBB
    Chairperson: Jim Lorens

    26.09.19, Karl Kadler

    Professor Karl Kadler, Director at the Wellcome Trust Centre for Cell-Matrix Research, Manchester, UK.
    TitleCircadian control of the secretory pathway is a central mechanism in tissue homeostasis
    Time: 14:30
    Place: Auditorium 4, BBB
    Chairperson: Donald Gullberg

    04.10.19, Clinical trials in the future

    CCBIO Mini Symposium. Speakers:
    Fredrik Öhrn, Gothenburg: Design of clinical trials in the future
    Donal LandersManchester: Digital experimental medicine in Oncology
    Ketil Widerberg, Oslo: How artificial intelligence can improve clinical trials
    The Norwegian Cancer Society: Use of patients as co-scientists / Decision aids
    Time: 12:30
    Place: Auditorium 4, BBB
    Chairpersons: Line Bjørge and Hani Gabra.

    31.10.19, Daniela Elena Costea

    Daniela Elena Costea, Associated Investigator at CCBIO and Professor in tumor pathology, Department of Clinical Medicine, Faculty of Medicine, University of Bergen.
    Title: “My sabbatical year at University of California, San Diego: Conditional expression of HPV16 E6/E7 onco-proteins and PIK3CA is sufficient to initiate HPV-associated carcinogenesis.”
    Time: Thursday October 31st at 14:30
    Place: Auditorium 4, BB-building
    Chairperson: Lars A. Akslen

    28.11.19, Speaker Curzio Ruegg

    Professor Curzio Ruegg, Department of Medicine, Faculty of Science, University of Fribourg, Switzerland.
    Title: Chemotherapy-induced immunological dormancy in breast cancer
    Time: 14:30
    Place: Auditorium 4, BBB
    Chairperson: Oddbjørn Straume

    12.12.19, Speaker Srinivas Malladi

    CCBIO Special Seminar with Dr. Srinivas Malladi from the Department of Pathology, UT Southwestern, Dallas.
    TitleMetastatic Latency - Models and Mechanisms
    Time: 14:30
    Place: Birkhaugsalen, 3rd floor Sentralblokken
    Chairperson: James Lorens

    12.12.19, Speaker Anders Goksøyr

    Professor Anders Goksøyr, Department of Biological Sciences (BIO), University of Bergen.
    TitleFrom feminized fish to obese mice – On endocrine and metabolic disruption in wildlife (and the lab)
    Time: 14:30
    Place: Birkhaugsalen, 3rd floor Sentralblokken
    Chairperson: Lars A. Akslen

    Seminars in 2018

    01.02.18, Helge Wiig

    Professor Helge Wiig, Department of Biomedicine, Faculty of Medicine, University of Bergen.
    Time: 14:30
    Chairperson: Lars A. Akslen
    Title: "Lessons from a black box –The extracellular microenvironment and lymphatics in malignant tissue"

    22.02.18, Ole Frithjof Norheim

    Professor Ole Frithjof Norheim, physician and professor in medical ethics at the Department of Global Public Health and Primary Care, University of Bergen, and adjunct professor at the Department of Global Health and Population, Harvard TH Chan School of Public Health. Norheim is also a CCBIO associate investigator.
    Time: 14:30
    Chairperson: Roger Strand
    Title: "Can biomarkers improve priority setting for new, expensive cancer drugs?"

    22.03.18, Aaron Meyer

    Assistant Professor Aaron Meyer, Department of Bioengineering, University of California at Los Angeles (UCLA).
    Time: 14:30
    Chairperson: Jim Lorens
    Title: "Engineering more precise and potent TAM-targeted therapies"

    26.04.18, Ian Mackenzie

    Professor Ian Mackenzie from the Centre for Cell Biology and Cutaneous Research, the Blizard Institute, Queen Mary University of London.
    Time: 14:30
    Chairperson: Anne Christine Johannessen
    Title: "Stem cell plasticity in head and neck cancers

    31.05.18, Aurora Martinez.

    Professor Aurora Martinez from the Department of Biomedicine, Faculty of Medicine, University of Bergen.
    Time: 14:30
    Chairperson: Camilla Krakstad
    Title: "Pharmacological chaperoning: a potential treatment for genetic diseases, including some cancer syndromes."

    07.06.18, Arvid Lundervold.

    Professor Arvid Lundervold from the Department of Biomedicine, Faculty of Medicine, University of Bergen.
    Time: 14:30
    Chairperson: Lars A. Akslen.
    Title: "Computational imaging and machine learning in biomedicine"

    30.08.18, Edna Cukierman

    Edna Cukierman from the Department of Cancer Biology, Fox Chase Cancer Center, Philadelphia, PA, USA
    Time: 14:30
    Chairperson: Donald Gullberg.
    Title: “Oncogenic synapses; stromal regulators of pancreatic cancer, metabolic support and innate immunosuppression”.  

    19.09.18, Bruce Zetter, Merle Jacob, Lars A. Akslen and Roger Strand

    CCBIO Special Seminar. Statements and reflection around the concept of excellence in research, incl. Harvard experiences. The seminar is organized as part of the CCBIO/Harvard INTPART partnership.
    Time: 13.00
    Title: "What is Scientfic Excellence?"

    20.09.18, Michael Rogers and Bruce Zetter

    CCBIO Special Seminar. The seminar is organized as part of the CCBIO/Harvard INTPART partnership.
    Time: 09.00-12.00
    Michael Rogers: "Validation of Anthrax Toxin Receptor 2 (Antxr2/CMG2) as a Target for Small Molecule Antiangiogenic Therapy."
    Bruce Zetter: "Drug discovery for treating metastatic cancers."
    Read more here.
     

    27.09.18, Staffan Strömblad

    Staffan Strömblad from the Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden
    Time: 14:30
    Chairperson: Donald Gullberg.
    Title: "Novel cell-matrix adhesion structures"

    03.10.18, Marsha Moses, Roland Jonsson, Roopali Roy, Anne Blanchard

    CCBIO Special Seminar. The seminar is organized as part of the CCBIO/Harvard INTPART partnership.
    Time: 13.00-16.00
    Title "The Importance of Mentoring for Career Development". The seminar will consist of short presentations, panel discussion and interactions with the audience.
    Note that location is not Aud. 4 at BBB this time, but B302 at Haukeland Univ. Hospital, Sentralblokka (main building), 3rd floor.

    25.10.18, Arne Östman

    Professor Arne Östman, Karolinska Institutet, Sweden, and also CCBIO international affiliated researcher.
    Time: 14:30
    Chairperson: Lars A. Akslen.
    Title:  "Prognostic and response-predictive potential of tumor-stroma cell subsets."

    29.11.18, Frédéric Amant

    Frédéric Amant from the Center for Gynecologic Oncology, Netherlands Cancer Institute and Academic Medical Center, Amsterdam, The Netherlands. Professor Amant is also one of CCBIO's international affiliated researchers.
    Time: 13:30 (Note: one hour earlier than usual)
    Chairperson: Elisabeth Wik.
    Title: "Cancer during pregnancy: a multidisciplinary approach in an INCIP research setting"

    13.12.18 - Cedric Zeltz

    Cedric Zeltz, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
    Time: 14:30
    Note: Auditorium is Birkhaugsalen this time, at Sentralblokken (Haukeland University Hospital main building), 3rd floor.
    Chairperson: Donald Gullberg.
    Title: "Importance of the tumor microenvironment in non-small cell lung cancer: Examples of stromal proteins as potential therapeutical targets"

     

    Seminars in 2017

    The seminar dates and speakers for 2017 are:

    26.01.17, Norman J. Maitland

    Norman J. Maitland, Department of Biology, University of York, UK.
    Time: 14:30
    Chairperson: Karl-Henning Kalland
    Title: Modelling of cell fate and differentiation using tissue-derived human prostate epithelial cells

    23.02.17, Øystein Bruserud

    Øystein Bruserud, the Leukaemia Research Group, Department of Clinical Science, University of Bergen, Norway.
    Time: 14:30
    Chairperson: Bjørn Tore Gjertsen
    Title: Classification and prognostication of acute myeloid leukemia – the past, the present and the future

    16.03.17, Klas Wiman

    Klas Wiman, the Department of Oncology-Pathology, Karolinska Institute, Sweden.
    Chairperson: Bjørn Tore Gjertsen
    Title: Targeting missense and nonsense mutant p53 in cancer – from molecular biology to the clinic

    27.04.17, Robert Lafyatis - CANCELLED

    Robert Lafyatis, Division of Rheumatology and Clinical Immunology,University of Pittsburgh Medical Center, USA.
    Chairperson: Donald Gullberg
    Title: Understanding cellular heterogeneity and fibrosis in systemic sclerosis skin using single cell RNAseq: SFRP2/DPP4 and FMO1/LSP1 define two major fibroblast populations in normal skin

    11.05.17, Ulf Landegren

    Ulf Landegren, Department of Immunology, Genetics and Pathology, Uppsala University, Sweden.
    Chairperson: Rolf Kåre Reed
    Title: Molecular tools for high performance analyses of proteins and nucleic acids

    15.06.17, Kalle Sipila

    Kalle Sipila, Centre for Stem Cells and Regenerative Medicine, King's College London, UK
    Chairperson: Donald Gullberg
    Title: Integrative genomic and functional analysis of human primary oral SCC cells

    28.09.17, Nuno M. Coelho 

    Nuno M. Coelho, Matrix Dynamics Group, University of Toronto
    Chairperson: Donald Gullberg
    Title: DDR1 expression, collagen-dependent activation and signalling in cancer and tissue fibrosis

    26.10.17, Jan Jacob Schuringa

    Jan Jacob SchuringaDepartment of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, The Netherlands
    Chairperson: Bjørn Tore Gjertsen
    Title: Towards identification and targeting of leukemic stem cells and (epi)genetically distinct subclones using humanized niche xenograft mouse models

    03.11.17, CCBIO Special Seminar, Rameen Beroukhim

    Rameen Beroukhim, Department of Medical Oncology and Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
    Chairperson: Lars A. Akslen
    Title: Structural variations in the cancer genome

    23.11.17, Satu Mustjoki

    Satu Mustjoki, Hematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Finland
    Chairperson: Bjørn Tore Gjertsen
    Title: Immunogenicity in hematological malignancies and immunological effects of targeted therapy

    12.12.17, CCBIO Special Seminar, Randolph Watnick

    Randolph Watnick, the Department of Surgery, Harvard Medical School and the Vascular Biology Program at Boston Children’s Hospital, USA.
    Chairperson: Lars A. Akslen
    Title: A novel mechanism governing tumor initiation and cancer stem cell function.

     

    Seminars in 2016

    28.01.2016, Jean-Christophe Bourdon

    Jean-Christophe Bourdon, Division of Cancer Research, Jacqui Wood Cancer Centre, University of Dundee, United Kingdom. 
    Time: 14:30
    Host: Bjørn Tore Gjertsen
    Title: A decade of research on p53 sumarised.

     

    25.02.2016, Olivier De Wever

    Olivier De Wever, Laboratory of Experimental Cancer Research, Ghent University, Belgium.
    Time: 14:30
    Host: Donald Gullberg
    Title: Communication in the tumor environment: diagnostic and therapeutic opportunities.

     

    17.03.2016, Lutz P. Müller

    Lutz P. Müller, MD; Clinic for Internal Medicine IV - Hematology / Oncology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
    Time: 14:30
    Host: Donald Gullberg
    Title: Growth promotion of colorectal cancer by mesenchymal stromal cells – when and how?

     

    28.04.2016, Krister Wennerberg

    Krister Wennerberg, Institute for Molecular Medicine Finland, University of Helsinki, Finland.
    Time: 14:30
    Host: Bjørn Tore Gjertsen
    Title: Targeting cancers using individual systems medicine

     

    26.05.2016 CCBIO Special Seminar

    Speaker: Anne Blanchard and invited speakers
    Time: 14:30
    Host: Roger Strand
    Title: Pharma and public cancer biomarker research in the transition from a blockbuster model to personalised medicine

     

    16.06.2016, Gwendalyn J. Randolph

    Gwendalyn J. Randolph, Division of Immunology, School of Medicine, Washington University in St. Lois, USA.
    Time: 14:30
    Host: Rolf K. Reed
    Title: The Lymphatic vasculature in immunity and inflammatory disease

     

    25.08.2016, Jonathan M. Irish

    Jonathan M. Irish, Department of Cancer Biology, Vanderbilt University, Nashville, TN, USA
    Time: 14:30, Auditorium 2.
    Host: James Lorens
    Title: Decoding human tumor microenvironments and healthy tissues using high dimensional single cell mass cytometry 

     

    29.09.2016, Herbert Schiller

    Herbert Schiller, Comprehensive Pneumology Center, Institute of Lung Biology and Disease, Helmholtz Zentrum München, Neuherberg, Germany
    Time: 14:30, Auditorium 4.
    Host: Donald Gullberg
    Title: Multi-dimensional proteomics of the extracellular matrix in regeneration and fibrosis

     

    27.10.2016

    27.10.16 is cancelled, new date will be announced.
    Time: 14.30, Auditorium 2
    Hosts: Jan Håvik and Donald Gullberg

     

    10.11.2016, CCBIO/OCC Network Meeting

    A joint R&D Network titled "Personalized Cancer Therapy: Repurposing and in vitro drug screens

    Time: 10:30-17.00, aud. 4 till lunchbreak, aud. 2 after lunchbreak, BB-building.

     

    01.12.2016, Jean-Paul Thiery

    Jean-Paul Thiery, Centre for Cancer Biomarkers CCBIO, The University of Bergen, Yong Loo Lin School of Medicine National University of Singapore, University Paris Denis Diderot, Paris, France and Comprehensive Cancer Center Institut Gustave Roussy, Villejuif, France.
    Title: "Epithelial cell plasticity in carcinoma: Harnessing mechanisms controlling biomechanics and progression of malignancy for the design of new therapeutic strategies"

    Time: 14.30, Auditorium 4
    Host: James B. Lorens

     

    15.12.2016, Kenneth Hugdahl

    Kenneth Hugdahl, Department of Biological and Medical Psychology, University of Bergen.
    Excellence in science: Experience with ERC Advanced Grants
    Time: 14:30, Auditorium 4.
    Host: Lars Akslen

    Seminars in 2015

     

    22.01.2015, John Cairns

    John Cairns, Centre for Cancer Biomarkers (CCBIO), Department of Economics, University of Bergen, and Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, United Kingdom.
    Time: 14:30
    Host: Roger Stand

    Title: "Assessing the cost-effectiveness of bevacizumab in the treatment of metastatic melanoma"

     

    19.02.2015, Anne Christine Johannessen

    Anne Christine Johannessen, Centre for Cancer Biomarkers (CCBIO), Department of Clinical Medicine, University of Bergen.
    Time: 14:30.
    Host: Roger Stand

    Title: "Oral cancer – ongoing research with special focus on tumour microenvironment"

     

    26.03.2015, Hani Gabra

    Hani Gabra, Department of Surgery and Cancer, Imperial College London, UK.
    Time: 14:30.
    Host: Helga Salvesen

    Title: "OPCML, a tumour suppressor and novel systems regulator of tyrosine kinase signalling in ovarian and other cancers"

     

    08.04.2015, Rik Thompson and John Haley

    CCBIO special seminar with keynote speakers:

    Rik Thompson, Queensland University of Technology, Brisbane Australia. See more introduction here to Rik Thompson.

    John D. Haley, Stony Brook School of Medicine New York, SBU Cancer Center and SBU Proteomics Center.

    Title: "Tumor plasticity and drug resistance
    Host: James Lorens.
    Time: 14:00-16.00.

     

    30.04.2015, Lorena Arranz

    Lorena Arranz, Stem Cell Aging and Cancer Research Group, Department of Medical Biology, UiT The Arctic University of Norway, Tromsø

    Title: Neuroglial dysregulation of the haematopoietic stem cell niche in myeloid leukaemias
    Time: 14:30.
    Host: Bjørn Tore Gjertsen

     

    28.05.2015, Neil C. Henderson

    Neil C. Henderson, MRC Centre for Inflammation Research, University of Edinburgh, UK.

    Title: Targeting of pericytes and tissue myofibroblasts during organ fibrogenesis
    Time: 14:30.
    Host: Donald Gullberg

     

    11.06.2015, Robert S. Kerbel

    A combined CCBIO and BBB seminar

    Robert S. Kerbel, Biological Sciences Platform, Sunnybrook Research Institute, Toronto, and Department of Medical Biophysics, University of Toronto, Canada

    Title: Antiangiogenic therapeutics in oncology: Overview, update, and future directions
    Time: 14:30
    Host: Oleg Tsinkalovsky

     

    27.08.2015, Roya Navab

    Speaker: Roya Navab, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

    Title: Integrin α11β1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer
    Time: 14:30.
    Host: Donald Gullberg

     

    24.09.2015, Bruce Baguley

    Speaker: Bruce Baguley, the Auckland Cancer Society Research Centre, The University of Auckland, New Zealand.

    Title: The importance of being... a receptor tyrosine kinase.
    Time: 14:30.
    Host: Jim Lorens

     

    15.10.2015, Matthew G. Krebs

    Combined BBB and CCBIO Seminar.

    Speaker: Matthew G. Krebs, Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, UK.

    Title: Circulating biomarkers in early phase drug development for lung cancer.
    Time: 14:30.
    Host: Bjørn Tore Gjertsen

     

    22.10.2015, Eric Sahai

    Speaker: Eric Sahai, the Francis Crick Institute, London.

    Title: The role of CAFs in therapy failure. Intravital imaging reveals how stroma dictates heterogeneous responses to targeted therapy.
    Time: 14:30. (NB: In Auditorium 1 at BBB this time.)
    Host: Donald Gullberg

     

    26.11.2015, Patrick Schöffski

    Speaker: Patrick Schöffski, the Laboratory of Experimental Oncology, the Department of Oncology, KU Leuven, Belgium.

    Title: “Modelling mesenchymal malignancies: development of patient-derived xenografts of soft tissue sarcomas and gastrointestinal stromal tumours and in vivo-drug testing with direct implications for clinical research (bedside to bench and back)
    Time: 14:30.
    Host: Bjørn Tore Gjertsen

     

    17.12.2015, Jarle Breivik

    Speaker: Jarle Breivik, Dept. of Behavioural Sciences in Medicine, Faculty of Medicine, University of Oslo

    Title: "Cancer and aging: Facing realities and an uncertain future".
    Time: 14:30.
    Host: Lars A. Akslen

     

     

     

    Seminars in 2014

    30.01.2014, Karl-Henning Kalland,

    Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen:
    Heterogeneity and reprogramming plasticity of cancer cells – therapeutic possibilities.

     

    20.02.2014: Roger Strand,

    Centre for Cancer Biomarkers (CCBIO) and Centre for the Study of the Sciences and the Humanities (SVT), University of Bergen:
    Crossing the Styx

     

    20.03.2014, Cédric Gaggioli,

    Institute for Research on Cancer and Aging (IRCAN), Nice, France:
    Production of LIF cytokine by cancer cells and fibroblasts contributes to the establishment of a pro-invasive tumor microenvironment.

     

    24.04.2014, Angela Nieto,

    Instituto de Neurociencias Consejo Superior de Investigaciones Científicas (CSIC)–Universidad Miguel Hernández (UMH), San Juan de Alicante, Spain:
    Epithelial plasticity in development and disease

     

    22.05.2014, Emmet McCormack,

    Department of Clinical Science, University of Bergen:
    Pharmacological inhibition of the SIRT1 deacetylase with the small molecule inhibitor Tenovin-6 enhances ablation of FLT3-ITD+ LSC in combination with TKI treatment.

     

    28.08.2014, Inge Jonassen

    Centre for Cancer Biomarkers and Computational Biology Unit, Department of Informatics, University of Bergen:

    Towards characterizing tumour microenvironments – experimental and computational approaches.

     

    02.10.2014, Zena Werb

    Department of Anatomy, and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA:

    New insights into mechanisms underlying breast cancer metastasis

     

    30.10.2014, Boris Hinz

    Laboratory of Tissue Repair and Regeneration, University of Toronto, Canada

    Myofibroblasts can have it all: matrix mechanics, integrins, and pro-fibrotic growth factor activation

     

    27.11.2014, Bjørn Tore Gjertsen

    Department of Clinical Science, University of Bergen

    Oncogene-addicted cancer: chronic myelogen leukemia as a model of a tyrosine kinase driven malignancy

     

    18.12.2014, Arne Östman

    Department of Oncology-Pathology, Karolinska Institutet,
    Stockholm, Sweden

    Impact of PDGFR-regulated fibroblasts and pericytes on tumor progression, prognosis and drug response

     

    Seminars in 2013

    29.8.2013: Lars A. Akslen.

    Director of CCBIO.

    CCBIO: Current concepts and challenges in cancer research.


    26.9.2013: Helga B. Salvesen.

    Co-Director of CCBIO.

    Individualized therapy based on molecular alterations in gynecologic cancer.


    31.10.2013: Oddbjørn Straume.

    CCBIO. Angiogenic biomarkers in malignant melanoma.
     

    25.11.2013: Sonja Loges.

    University Hospital Hamburg-Eppendorf, University Comprehensive Cancer. Center II, Medical Clinic & Institute of Tumor Biology. CCBIO Special Lecture:
    Role of Gas6 - Axl axis in malignant interaction with the host.
     

    28.11.2013: Bjørn Tore Gjertsen.

    CCBIO. Phosphoprotein signaling in acute myeloid leukemia.

     

    PRACTICAL INFORMATION

    About the CCBIO Seminars
    The CCBIO Seminar series covers the full spectrum of research areas within CCBIO's research focus. Talks are held mainly by invited international speakers. Before each semester, it is possible to suggest speakers for the next semester of CCBIO Seminars. CCBIO provides financing for inviting speakers. The CCBIO Seminars series is part of a master- and a PhD course programme, BMED380 and CCBIO902 respectively, and is open to all that are interested in biomedical and biosciences research. Registration to the courses can be done at StudentWeb (for students requiring ECTS). Audience not requiring ECTS registration, does not need to register.

    Place, time, transport
    The seminars are normally held at BBB, Jonas Lies vei 91, 3rd floor, in auditorium 4, usually at 14.30 one Thursday per month. The auditorium is up the stairs on the right hand side after passing the reception at the BBB main entrance or is straight on when coming via the pedestrian bridge from Haukeland Hospital. For transport from downtown Bergen, you can consider using the Campusbussen.

    CCBIO Special Seminars: Please inform us about your guests
    If a renowned scientist within a relevant field is going to visit your group and would be willing to give a talk under the umbrella of the CCBIO Special Seminars, please let us know. If approved as a Special Seminar, CCBIO will provide financing and assist with marketing as well as ordering pizza for an informal get-together following the talk. Contact Donald Gullberg if you have suggestions for speakers for the CCBIO Seminars at the scheduled dates or for a CCBIO Special Seminar outside these dates.

    CALL FOR PROPOSALS, FINANCING AND INFORMATION FOR HOSTS

    If you want to suggest a speaker to any of the open slots, please get in touch with Donald Gullberg per email. In the email, you should include the following information: A short motivation, topic suggestion, a short bio of 4-5 lines, affiliation, CV or publication list and webpage of the speaker. CCBIO will select speakers among those suggested, using the following criteria: scientific excellence, topic of general interest, topic diversity. For CCBIO Special Seminars, please include what date you suggest for the talk. We prefer you to arrange for booking of one of the auditoria in the BB-Building for the CCBIO Special Seminar.

    Travel costs and reimbursement
    CCBIO will contribute with travel and accommodation costs for the selected speakers with up to 15 000 NOK for overseas speakers and 8 000 NOK for European speakers. The rest will need to be covered by your funds. For flights, hotel and reimbursement you need to interact with your own department's administration according to your own department's procedures. Your financial officers can forward your part of the cost to CCBIO's financial coordinator Mildrid Bønes Høgås.

    Your responsibilities as a host
    If CCBIO agrees to your proposed guest speaker, you will be acting as host.

    This involves sending the following to Eli.Vidhammer@uib.no :

    • The short bio of 4-5 lines, affiliation, webpage of the speaker with bio and publication list, immediately after your candidate has been accepted by CCBIO.
    • A seminar title (as soon as possible after accepting, it can be changed later) as well as an abstract (approx. ½ a page; to be provided at the latest two weeks before the seminar).
    • You must inform the speaker 1) to give a general introduction at the start, 2) that the audience is composed of students, postdocs and faculty with diverse backgrounds, 3) to limit the lecture to approx. 45 min.

    In terms of logistics, following up your guest and the seminar itself, you need to:

    • Act as a liaison between the speaker and your own department's administration regarding transport and accommodation for the guest as well as reimbursement of travelling costs.
    • Arrange a social program for the guest during his/her stay.
    • Setup of the ppt.-presentation in the auditorium together with the speaker in due time before the start of the seminar. In case you prefer technical assistance, please contact Torstein Ravnskog at least one day in advance.
    • Ask the speaker to give a general introduction at the beginning of the talk placing his/her work/results into a broader perspective. Informing him/her that the lecture should not greatly exceed 45 minutes.
    • Chair the seminar which includes introducing the speaker and leading the discussion.
    • Snap some photos during the seminar, or make sure someone else does, for use in the CCBIO Annual Report, to be sent to Eli.Vidhammer@uib.no along with a short text about the seminar (topic, speaker, interesting points raised in the talk...)

     

     

    CCBIO SPECIAL SEMINARS

    If a renowned scientist within a relevant field is going to visit your group and would be willing to give a talk under the umbrella of CCBIO's Special Seminars, please let us know. If approved as a Special Seminar, CCBIO will provide financing and assist with marketing as well as ordering pizza for an informal get-together following the talk. 

    Contact Donald Gullberg if you have suggestions for speakers for the CCBIO Seminars at the scheduled dates and Geir Olav Løken if you would like to suggest a CCBIO Special Seminar outside these dates. In the email, you should include the following information: Affiliation, CV or publication list and webpage of the speaker and a short motivation. CCBIO will select the speakers among those suggested, using the following criteria: scientific excellence, topic of general interest, topic diversity.

    Please see the menu point «CALL FOR PROPOSALS, FINANCING AND INFORMATION FOR HOSTS» for practicalities.

    For CCBIO Special Seminars you or your group need to book of one of the auditoria in the BB-Building (preferably Auditorium 4, or elsewhere if the BBB auditoria are not available) and to ensure that you have access to the room you have booked.